about
Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablationDo fish oil omega-3 fatty acids enhance antioxidant capacity and mitochondrial fatty acid oxidation in human atrial myocardium via PPARγ activation?Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase.G protein-coupled receptor kinase 5 gene polymorphisms are associated with postoperative atrial fibrillation after coronary artery bypass grafting in patients receiving β-blockersHeart failure and atrial fibrillation: from basic science to clinical practiceThe loss of cellular junctions in epithelial lung cells induced by cigarette smoke is attenuated by corilaginRole of RBM25/LUC7L3 in abnormal cardiac sodium channel splicing regulation in human heart failure.Metabolic stress, reactive oxygen species, and arrhythmia.Small heat shock proteins in redox metabolism: implications for cardiovascular diseases.RBM25/LUC7L3 function in cardiac sodium channel splicing regulation of human heart failure.Angiotensin receptor blockers and statins could alleviate atrial fibrosis via regulating platelet-derived growth factor/Rac1/nuclear factor-kappa B Axis.Gene signatures of postoperative atrial fibrillation in atrial tissue after coronary artery bypass grafting surgery in patients receiving β-blockers.The NO/ONOO-cycle as the central cause of heart failure.Drosophila models of cardiac disease.CPU228, a derivative of dofetilide, relieves cardiac dysfunction by normalizing FKBP12.6, NADPH oxidase and protein kinase C epsilon in the myocardium.Ceruloplasmin and atrial fibrillation: evidence of causality from a population-based Mendelian randomization study.DL-3-n-Butylphthalide reduces atrial fibrillation susceptibility by inhibiting atrial structural remodeling in rats with heart failure.The immunoproteasome subunit LMP10 mediates angiotensin II-induced retinopathy in mice.
P2860
Q26864767-722CF633-BB99-4436-A670-C1D9DDF0FAD0Q34082184-29D0A46E-F2BD-4B86-861E-0327D068E530Q34651371-EB36C2EB-F537-4DB3-B519-E78B5488B165Q34735239-74C70D3F-FD39-4BB2-8435-74592DBA6ABAQ35138993-3B645A4C-154E-4AA2-A299-254E84E6D94AQ35162508-F4A6355D-E55E-4B6E-BBA4-91DC2D62E61BQ35210482-2867B9E2-574E-413D-84C0-379E42448DBAQ35690954-F4FE6489-42C4-417D-ACCD-CD55EBE635D0Q36143828-4BCA056A-712E-42F9-A1AC-10C3EFF61267Q36494631-02C04F55-9CA8-4ADF-9BCC-789123115A41Q36947457-613CCEC4-4B45-4D29-8ECA-CE5ED48F85A3Q37139997-249CD548-ACE8-4877-890C-85D5BBEC8C59Q37375441-D50F4AE8-82FD-4EA1-A512-B453D8AB12BFQ37850142-D1EB84C6-9BCA-4E69-BA07-A6650BAF3173Q42932530-BE808FC5-D4BF-49F2-AA81-87CAAACD7CF8Q44516862-CFBBE9B1-5241-4D34-A4E9-BC220D5FED43Q47242186-48E4E87C-98AE-4B8D-987C-A1DA4777723AQ51736597-8B60A30E-47C2-4E3D-9703-F8CDDB76B6B8
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Redox regulation, NF-kappaB, and atrial fibrillation.
@ast
Redox regulation, NF-kappaB, and atrial fibrillation.
@en
type
label
Redox regulation, NF-kappaB, and atrial fibrillation.
@ast
Redox regulation, NF-kappaB, and atrial fibrillation.
@en
prefLabel
Redox regulation, NF-kappaB, and atrial fibrillation.
@ast
Redox regulation, NF-kappaB, and atrial fibrillation.
@en
P2860
P356
P1476
Redox regulation, NF-kappaB, and atrial fibrillation
@en
P2093
P2860
P304
P356
10.1089/ARS.2009.2595
P577
2009-09-01T00:00:00Z